These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 24786788)

  • 1. Oncogenic protein MTBP interacts with MYC to promote tumorigenesis.
    Grieb BC; Gramling MW; Arrate MP; Chen X; Beauparlant SL; Haines DS; Xiao H; Eischen CM
    Cancer Res; 2014 Jul; 74(13):3591-602. PubMed ID: 24786788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An ATPase/helicase complex is an essential cofactor for oncogenic transformation by c-Myc.
    Wood MA; McMahon SB; Cole MD
    Mol Cell; 2000 Feb; 5(2):321-30. PubMed ID: 10882073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A deficiency in Mdm2 binding protein inhibits Myc-induced B-cell proliferation and lymphomagenesis.
    Odvody J; Vincent T; Arrate MP; Grieb B; Wang S; Garriga J; Lozano G; Iwakuma T; Haines DS; Eischen CM
    Oncogene; 2010 Jun; 29(22):3287-96. PubMed ID: 20305689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MTBP regulates cell survival and therapeutic sensitivity in TP53 wildtype glioblastomas.
    Song Y; Zhang L; Jiang Y; Hu T; Zhang D; Qiao Q; Wang R; Wang M; Han S
    Theranostics; 2019; 9(20):6019-6030. PubMed ID: 31534534
    [No Abstract]   [Full Text] [Related]  

  • 5. BAF53 forms distinct nuclear complexes and functions as a critical c-Myc-interacting nuclear cofactor for oncogenic transformation.
    Park J; Wood MA; Cole MD
    Mol Cell Biol; 2002 Mar; 22(5):1307-16. PubMed ID: 11839798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MTBP is overexpressed in triple-negative breast cancer and contributes to its growth and survival.
    Grieb BC; Chen X; Eischen CM
    Mol Cancer Res; 2014 Sep; 12(9):1216-24. PubMed ID: 24866769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pontin and Reptin regulate cell proliferation in early Xenopus embryos in collaboration with c-Myc and Miz-1.
    Etard C; Gradl D; Kunz M; Eilers M; Wedlich D
    Mech Dev; 2005 Apr; 122(4):545-56. PubMed ID: 15804567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MTBP and MYC: A Dynamic Duo in Proliferation, Cancer, and Aging.
    Grieb BC; Eischen CM
    Biology (Basel); 2022 Jun; 11(6):. PubMed ID: 35741402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myc interacts genetically with Tip48/Reptin and Tip49/Pontin to control growth and proliferation during Drosophila development.
    Bellosta P; Hulf T; Balla Diop S; Usseglio F; Pradel J; Aragnol D; Gallant P
    Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11799-804. PubMed ID: 16087886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haploinsufficiency of the Myc regulator Mtbp extends survival and delays tumor development in aging mice.
    Grieb BC; Boyd K; Mitra R; Eischen CM
    Aging (Albany NY); 2016 Oct; 8(10):2590-2602. PubMed ID: 27803394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TIP49, but not TRRAP, modulates c-Myc and E2F1 dependent apoptosis.
    Dugan KA; Wood MA; Cole MD
    Oncogene; 2002 Aug; 21(38):5835-43. PubMed ID: 12185582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity.
    Kim J; Roh M; Abdulkadir SA
    BMC Cancer; 2010 Jun; 10():248. PubMed ID: 20515470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting MYC effector functions in pancreatic cancer by inhibiting the ATPase RUVBL1/2.
    Vogt M; Dudvarski Stankovic N; Cruz Garcia Y; Hofstetter J; Schneider K; Kuybu F; Hauck T; Adhikari B; Hamann A; Rocca Y; Grysczyk L; Martin B; Gebhardt-Wolf A; Wiegering A; Diefenbacher M; Gasteiger G; Knapp S; Saur D; Eilers M; Rosenfeldt M; Erhard F; Vos SM; Wolf E
    Gut; 2024 Aug; 73(9):1509-1528. PubMed ID: 38821858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The non-enzymatic RAS effector RASSF7 inhibits oncogenic c-Myc function.
    Kumaraswamy A; Mamidi A; Desai P; Sivagnanam A; Perumalsamy LR; Ramakrishnan C; Gromiha M; Rajalingam K; Mahalingam S
    J Biol Chem; 2018 Oct; 293(40):15691-15705. PubMed ID: 30139745
    [No Abstract]   [Full Text] [Related]  

  • 15. MYC Protein Interactome Profiling Reveals Functionally Distinct Regions that Cooperate to Drive Tumorigenesis.
    Kalkat M; Resetca D; Lourenco C; Chan PK; Wei Y; Shiah YJ; Vitkin N; Tong Y; Sunnerhagen M; Done SJ; Boutros PC; Raught B; Penn LZ
    Mol Cell; 2018 Dec; 72(5):836-848.e7. PubMed ID: 30415952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis.
    Aprelikova O; Chen K; El Touny LH; Brignatz-Guittard C; Han J; Qiu T; Yang HH; Lee MP; Zhu M; Green JE
    Clin Epigenetics; 2016; 8():38. PubMed ID: 27081402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleophosmin interacts directly with c-Myc and controls c-Myc-induced hyperproliferation and transformation.
    Li Z; Boone D; Hann SR
    Proc Natl Acad Sci U S A; 2008 Dec; 105(48):18794-9. PubMed ID: 19033198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MTBP Promotes the Invasion and Metastasis of Hepatocellular Carcinoma by Enhancing the MDM2-Mediated Degradation of E-Cadherin.
    Lu S; Zhou W; Wei H; He L; Li L
    Dig Dis Sci; 2015 Dec; 60(12):3681-90. PubMed ID: 26280083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MTBP suppresses cell migration and filopodia formation by inhibiting ACTN4.
    Agarwal N; Adhikari AS; Iyer SV; Hekmatdoost K; Welch DR; Iwakuma T
    Oncogene; 2013 Jan; 32(4):462-70. PubMed ID: 22370640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MTBP inhibits migration and metastasis of hepatocellular carcinoma.
    Bi Q; Ranjan A; Fan R; Agarwal N; Welch DR; Weinman SA; Ding J; Iwakuma T
    Clin Exp Metastasis; 2015 Apr; 32(4):301-11. PubMed ID: 25759210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.